Does Glanbia's (ISE:GL9) Statutory Profit Adequately Reflect Its Underlying Profit?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability suggests a business is sustainable. That said, the current statutory profit is not always a good guide to a company's underlying profitability. This article will consider whether Glanbia's (ISE:GL9) statutory profits are a good guide to its underlying earnings.

While Glanbia was able to generate revenue of €3.88b in the last twelve months, we think its profit result of €180.2m was more important. While it managed to grow its revenue over the last three years, its profit has moved in the other direction, as you can see in the chart below.

Check out our latest analysis for Glanbia

ISE:GL9 Income Statement May 4th 2020
ISE:GL9 Income Statement May 4th 2020

Importantly, statutory profits are not always the best tool for understanding a company's true earnings power, so it's well worth examining profits in a little more detail. This article will focus on the impact unusual items have had on Glanbia's statutory earnings. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Advertisement

How Do Unusual Items Influence Profit?

Importantly, our data indicates that Glanbia's profit was reduced by €39m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Glanbia doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

Our Take On Glanbia's Profit Performance

Because unusual items detracted from Glanbia's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Based on this observation, we consider it likely that Glanbia's statutory profit actually understates its earnings potential! On the other hand, its EPS actually shrunk in the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. While conducting our analysis, we found that Glanbia has 2 warning signs and it would be unwise to ignore these bad boys.

This note has only looked at a single factor that sheds light on the nature of Glanbia's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About ISE:GL9

Glanbia

Operates as a nutrition company worldwide.

Excellent balance sheet with proven track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
GIFT logo
Lou_Basenese on Giftify ·

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

Fair Value:US$2.564.5% undervalued
62 users have followed this narrative
2 users have commented on this narrative
12 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6526.7% undervalued
16 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
JD
CELH logo
JD009 on Celsius Holdings ·

From $5M to $2B: Why the 2024 Crash Was the Best Buying Opportunity in Consumer Stocks

Fair Value:US$55.4346.2% undervalued
5 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
WA
ACN logo
Wavefarer on Accenture ·

High-quality global services company facing an AI-driven valuation reset.

Fair Value:US$30154.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

VA
Valtersa
1180 logo
Valtersa on Saudi National Bank ·

Projected Fair Value of Saudi National Bank Reaches 52

Fair Value:ر.س5226.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ON
ARREIT logo
Ontological on AmanahRaya Real Estate Investment Trust ·

Income Focused ARREIT

Fair Value:RM 0.21104.8% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
BSY logo
browser on Bentley Systems ·

Bentley Systems’ Strategic Positioning in the Digital Infrastructure Cycle

Fair Value:US$15.72102.0% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75028.3% undervalued
89 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
CBRS logo
BlackGoat on Cerebras Systems ·

The Wafer Giant Threatening NVIDIA's GPU Hegemony

Fair Value:US$415.5450.8% undervalued
61 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative
CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3459.2% undervalued
60 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative